EDWARDS LIFESCIENCES CORPORATION
Latest Quote @ Fri May 5 09:42:13 (15 min delayed)
Last Day's Data
Edwards Lifesciences Corporation provides products and technologies designed to treat advanced cardiovascular disease. It provides products and technologies to address heart valve disease, peripheral vascular disease, and critical care technologies. The company's products and technologies are categorized into five areas: heart valve therapy, critical care, cardiac surgery systems, vascular, and other distributed products. Its heart valve therapy portfolio comprises tissue heart valves and heart valve repair products that are used to replace or repair a patient's diseased or defective heart valve. In the critical care area, the company provides hemodynamic monitoring systems used to measure a patient's heart function, as well as disposable pressure transducers and central venous access products for fluid and drug delivery. The company's cardiac surgery systems portfolio consists of a diverse line of products, including oxygenators, blood containers, filters, and other disposable products used during cardiopulmonary bypass procedures, cannulae, and transmyocardial revascularization technology. Edwards Lifesciences' vascular portfolio includes a line of balloon catheter-based products, surgical clips and inserts, angioscopy equipment, artificial implantable grafts, and stents used in the treatment of peripheral vascular disease. In addition, the company's other distributed products include intra-aortic balloon pumps, pacemakers, and other products. It distributes its products through direct sales force and independent distributors primarily in the United States, Canada, and Europe. Edwards Lifesciences was incorporated in 1999 and is headquartered in Irvine, California.